| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 55.5K | $1.02M | $18.33 | May 15, 2025 | Direct |
| FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
| aTYR PHARMA INC | Director | Common Stock | 56K | $98K | $1.75 | May 30, 2024 | Indirect |
| ADC Therapeutics SA | Director | Common Shares | 40K | $53.6K | $1.34 | Jun 3, 2025 | Direct |
| ADC Therapeutics SA | Director | Stock Options (Right to Buy) | 80K | Jun 3, 2025 | Direct | ||
| aTYR PHARMA INC | Director | Stock Option (right to buy) | 50K | May 1, 2025 | Direct | ||
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | Jun 3, 2025 | 2 | $0 | 4 | Jun 5, 2025 | Director |
| ADCT | ADC Therapeutics SA | Jun 3, 2025 | 0 | $0 | 3 | Jun 5, 2025 | Director |
| TVTX | Travere Therapeutics, Inc. | May 15, 2025 | 2 | $0 | 4 | May 16, 2025 | Director |
| ATYR | aTYR PHARMA INC | May 1, 2025 | 1 | $0 | 4 | May 2, 2025 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| LIFE | aTYR PHARMA INC | May 30, 2024 | 1 | $87.5K | 4 | Jun 3, 2024 | Director |
| LIFE | aTYR PHARMA INC | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| TVTX | Travere Therapeutics, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
| LIFE | aTYR PHARMA INC | May 17, 2023 | 3 | $0 | 4 | May 19, 2023 | Director |
| TVTX | Travere Therapeutics, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
| LIFE | aTYR PHARMA INC | Apr 26, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 3, 2022 | 1 | -$32.8K | 4 | Jun 6, 2022 | Director |
| TVTX | Travere Therapeutics, Inc. | May 11, 2022 | 2 | $0 | 4 | May 12, 2022 | Director |
| LIFE | aTYR PHARMA INC | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Director |
| FATE | FATE THERAPEUTICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| TVTX | Travere Therapeutics, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |